Ankur Dhingra - Net Worth and Insider Trading
Ankur Dhingra Net Worth
The estimated net worth of Ankur Dhingra is at least $7 Million dollars as of 2024-12-28. Ankur Dhingra is the CFO of Summit Therapeutics Inc and owns about 354,958 shares of Summit Therapeutics Inc (SMMT) stock worth over $6 Million. Ankur Dhingra is also the CFO of CareDx Inc and owns about 19,500 shares of CareDx Inc (CDNA) stock worth over $411,255. Details can be seen in Ankur Dhingra's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ankur Dhingra has not made any transactions after 2024-03-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ankur Dhingra
Ankur Dhingra Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ankur Dhingra owns 2 companies in total, including CareDx Inc (CDNA) , and Summit Therapeutics Inc (SMMT) .
Click here to see the complete history of Ankur Dhingra’s form 4 insider trades.
Insider Ownership Summary of Ankur Dhingra
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDNA | CareDx Inc | 2021-11-24 | Chief Financial Officer |
| SMMT | Summit Therapeutics Inc | 2024-03-26 | Chief Financial Officer |
Ankur Dhingra Latest Holdings Summary
Ankur Dhingra currently owns a total of 2 stocks. Among these stocks, Ankur Dhingra owns 354,958 shares of Summit Therapeutics Inc (SMMT) as of March 26, 2024, with a value of $6 Million and a weighting of 94.02%. Ankur Dhingra also owns 19,500 shares of CareDx Inc (CDNA) as of November 24, 2021, with a value of $411,255 and a weighting of 5.98%.
Latest Holdings of Ankur Dhingra
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc | 2024-03-26 | 354,958 | 18.21 | 6,463,785 |
| CDNA | CareDx Inc | 2021-11-24 | 19,500 | 21.09 | 411,255 |
Holding Weightings of Ankur Dhingra
Ankur Dhingra Form 4 Trading Tracker
According to the SEC Form 4 filings, Ankur Dhingra has made a total of 5 transactions in Summit Therapeutics Inc (SMMT) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Summit Therapeutics Inc is the acquisition of 100,000 shares on March 26, 2024, which cost Ankur Dhingra around $375,000.
According to the SEC Form 4 filings, Ankur Dhingra has made a total of 1 transactions in CareDx Inc (CDNA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CareDx Inc is the acquisition of 5,000 shares on November 24, 2021, which cost Ankur Dhingra around $211,700.
Insider Trading History of Ankur Dhingra
- 1
Ankur Dhingra Trading Performance
GuruFocus tracks the stock performance after each of Ankur Dhingra's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ankur Dhingra is 38.91%. GuruFocus also compares Ankur Dhingra's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ankur Dhingra within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ankur Dhingra's insider trading performs compared to the benchmark.
Performance of Ankur Dhingra
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.35 | | | | | |
| Relative Return to S&P 500(%) | 20.17 | | | | | |
Ankur Dhingra Ownership Network
Ankur Dhingra Owned Company Details
What does CareDx Inc do?
Who are the key executives at CareDx Inc?
Ankur Dhingra is the Chief Financial Officer of CareDx Inc. Other key executives at CareDx Inc include director & President and CEO Peter Maag , Chief Business Officer Alexander L Johnson , and See Remarks Reginald Seeto .
CareDx Inc (CDNA) Insider Trades Summary
Over the past 18 months, Ankur Dhingra made no insider transaction in CareDx Inc (CDNA). Other recent insider transactions involving CareDx Inc (CDNA) include a net sale of 17,110 shares made by Reginald Seeto , a net sale of 45,552 shares made by Peter Maag , and a net sale of 95,254 shares made by Alexander L Johnson .
In summary, during the past 3 months, insiders sold 13,674 shares of CareDx Inc (CDNA) in total and bought 0 shares, with a net sale of 13,674 shares. During the past 18 months, 166,590 shares of CareDx Inc (CDNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 166,590 shares.
CareDx Inc (CDNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
CareDx Inc Insider Transactions
Ankur Dhingra Mailing Address
Above is the net worth, insider trading, and ownership report for Ankur Dhingra. You might contact Ankur Dhingra via mailing address: C/o Caredx, Inc., 1 Tower Place, 9th Floor, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
